Security key
G8807B106
Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)
CUSIP: G8807B106
Q4 2017 13F Holders as of 31 Dec 2017
- Security type / class
- Equity / Ordinary Share $0.00001 Par Value
- Total 13F shares
- 46,927,458
- Total 13F value
- $1,308,786,945
- Share change
- -412,030
- SEC-reported price per share
- $27.89
- Number of holders
- 79
- Value change
- -$13,545,795
- Number of buys
- 38
- Number of sells
- 37
- Shares outstanding
- 51,428,000
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2017
Institutions
79
Top holders
10
TBPH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2018
Previous quarter: Q3 2017
Theravance Biopharma, Inc. SEC filings
Theravance Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G8807B106
Recent filing periods:
Ownership snapshot
Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Woodford Investment Manag...
Disclosed value leader
Woodford Investment Manag...
Comparable rows
15/15
Latest evidence
30 Sep 2017
13F
Lead comparable stake: 21%
Showing 1-6 of 15 holder rows.
Quick read
Woodford Investment Management Ltd leads the comparable SEC ownership view at 21%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Woodford Investment Management Ltd's linked filing trail.
Comparable ownership
Top 5
Woodford Investment Management Ltd
21%
BAUPOST GROUP LLC/MA
18%
FMR LLC
15%
BlackRock Finance, Inc.
7.4%
VANGUARD GROUP INC
6.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Woodford Investment Management Ltd |
13F
Company
|
21%
|
$366,577,000
10,706,108 shares
|
— | 30 Sep 2017 |
| BAUPOST GROUP LLC/MA |
13F
Company
|
18%
|
$318,746,000
9,309,168 shares
|
— | 30 Sep 2017 |
| FMR LLC |
13F
Company
|
15%
|
$270,664,000
7,904,898 shares
|
— | 30 Sep 2017 |
| BlackRock Finance, Inc. |
13F
Company
|
7.4%
|
$130,292,000
3,805,227 shares
|
— | 30 Sep 2017 |
| VANGUARD GROUP INC |
13F
Company
|
6.4%
|
$112,754,000
3,293,055 shares
|
— | 30 Sep 2017 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
4.5%
|
$78,762,000
2,300,296 shares
|
— | 30 Sep 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
79
Shares
46,927,458
Rows available
79
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
80
Q4 2017 holders
79
Holder diff
-1
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 value | Q4 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend